Sulfadiazine API Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
This report aims to provide a comprehensive presentation of the global market for Sulfadiazine API study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Sulfadiazine API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sulfadiazine API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Sulfadiazine API companies in 2021 (%)
The global Sulfadiazine API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity Above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sulfadiazine API include Nanhai Beisha Pharmaceutical, Hunan Xiangyikang Pharmaceutical, China Resources Double-crane Pharmaceutical, Yichang Humanwell Pharmaceutical, Northeast Pharmaceutical Group, Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical, Southwest Synthetic Pharmaceutical, Shanghai Zhongxi Sunve Pharmaceutical and Chongqing Kangle Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Sulfadiazine API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Sulfadiazine API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Sulfadiazine API Market Segment Percentages, by Type, 2021 (%)
Purity Above 99%
Purity Below 99%
Global Sulfadiazine API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Sulfadiazine API Market Segment Percentages, by Application, 2021 (%)
Tablet
Ointment
Others
Global Sulfadiazine API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Sulfadiazine API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sulfadiazine API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sulfadiazine API revenues share in global market, 2021 (%)
Key companies Sulfadiazine API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Sulfadiazine API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nanhai Beisha Pharmaceutical
Hunan Xiangyikang Pharmaceutical
China Resources Double-crane Pharmaceutical
Yichang Humanwell Pharmaceutical
Northeast Pharmaceutical Group
Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical
Southwest Synthetic Pharmaceutical
Shanghai Zhongxi Sunve Pharmaceutical
Chongqing Kangle Pharmaceutical
Adia (Shanghai) Pharma
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Sulfadiazine API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sulfadiazine API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sulfadiazine API Overall Market Size
2.1 Global Sulfadiazine API Market Size: 2021 VS 2028
2.2 Global Sulfadiazine API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sulfadiazine API Sales: 2017-2028
3 Company Landscape
3.1 Top Sulfadiazine API Players in Global Market
3.2 Top Global Sulfadiazine API Companies Ranked by Revenue
3.3 Global Sulfadiazine API Revenue by Companies
3.4 Global Sulfadiazine API Sales by Companies
3.5 Global Sulfadiazine API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sulfadiazine API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sulfadiazine API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sulfadiazine API Players in Global Market
3.8.1 List of Global Tier 1 Sulfadiazine API Companies
3.8.2 List of Global Tier 2 and Tier 3 Sulfadiazine API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sulfadiazine API Market Size Markets, 2021 & 2028
4.1.2 Purity Above 99%
4.1.3 Purity Below 99%
4.2 By Type - Global Sulfadiazine API Revenue & Forecasts
4.2.1 By Type - Global Sulfadiazine API Revenue, 2017-2022
4.2.2 By Type - Global Sulfadiazine API Revenue, 2023-2028
4.2.3 By Type - Global Sulfadiazine API Revenue Market Share, 2017-2028
4.3 By Type - Global Sulfadiazine API Sales & Forecasts
4.3.1 By Type - Global Sulfadiazine API Sales, 2017-2022
4.3.2 By Type - Global Sulfadiazine API Sales, 2023-2028
4.3.3 By Type - Global Sulfadiazine API Sales Market Share, 2017-2028
4.4 By Type - Global Sulfadiazine API Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Sulfadiazine API Market Size, 2021 & 2028
5.1.2 Tablet
5.1.3 Ointment
5.1.4 Others
5.2 By Application - Global Sulfadiazine API Revenue & Forecasts
5.2.1 By Application - Global Sulfadiazine API Revenue, 2017-2022
5.2.2 By Application - Global Sulfadiazine API Revenue, 2023-2028
5.2.3 By Application - Global Sulfadiazine API Revenue Market Share, 2017-2028
5.3 By Application - Global Sulfadiazine API Sales & Forecasts
5.3.1 By Application - Global Sulfadiazine API Sales, 2017-2022
5.3.2 By Application - Global Sulfadiazine API Sales, 2023-2028
5.3.3 By Application - Global Sulfadiazine API Sales Market Share, 2017-2028
5.4 By Application - Global Sulfadiazine API Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Sulfadiazine API Market Size, 2021 & 2028
6.2 By Region - Global Sulfadiazine API Revenue & Forecasts
6.2.1 By Region - Global Sulfadiazine API Revenue, 2017-2022
6.2.2 By Region - Global Sulfadiazine API Revenue, 2023-2028
6.2.3 By Region - Global Sulfadiazine API Revenue Market Share, 2017-2028
6.3 By Region - Global Sulfadiazine API Sales & Forecasts
6.3.1 By Region - Global Sulfadiazine API Sales, 2017-2022
6.3.2 By Region - Global Sulfadiazine API Sales, 2023-2028
6.3.3 By Region - Global Sulfadiazine API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sulfadiazine API Revenue, 2017-2028
6.4.2 By Country - North America Sulfadiazine API Sales, 2017-2028
6.4.3 US Sulfadiazine API Market Size, 2017-2028
6.4.4 Canada Sulfadiazine API Market Size, 2017-2028
6.4.5 Mexico Sulfadiazine API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sulfadiazine API Revenue, 2017-2028
6.5.2 By Country - Europe Sulfadiazine API Sales, 2017-2028
6.5.3 Germany Sulfadiazine API Market Size, 2017-2028
6.5.4 France Sulfadiazine API Market Size, 2017-2028
6.5.5 U.K. Sulfadiazine API Market Size, 2017-2028
6.5.6 Italy Sulfadiazine API Market Size, 2017-2028
6.5.7 Russia Sulfadiazine API Market Size, 2017-2028
6.5.8 Nordic Countries Sulfadiazine API Market Size, 2017-2028
6.5.9 Benelux Sulfadiazine API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sulfadiazine API Revenue, 2017-2028
6.6.2 By Region - Asia Sulfadiazine API Sales, 2017-2028
6.6.3 China Sulfadiazine API Market Size, 2017-2028
6.6.4 Japan Sulfadiazine API Market Size, 2017-2028
6.6.5 South Korea Sulfadiazine API Market Size, 2017-2028
6.6.6 Southeast Asia Sulfadiazine API Market Size, 2017-2028
6.6.7 India Sulfadiazine API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sulfadiazine API Revenue, 2017-2028
6.7.2 By Country - South America Sulfadiazine API Sales, 2017-2028
6.7.3 Brazil Sulfadiazine API Market Size, 2017-2028
6.7.4 Argentina Sulfadiazine API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sulfadiazine API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sulfadiazine API Sales, 2017-2028
6.8.3 Turkey Sulfadiazine API Market Size, 2017-2028
6.8.4 Israel Sulfadiazine API Market Size, 2017-2028
6.8.5 Saudi Arabia Sulfadiazine API Market Size, 2017-2028
6.8.6 UAE Sulfadiazine API Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Nanhai Beisha Pharmaceutical
7.1.1 Nanhai Beisha Pharmaceutical Corporate Summary
7.1.2 Nanhai Beisha Pharmaceutical Business Overview
7.1.3 Nanhai Beisha Pharmaceutical Sulfadiazine API Major Product Offerings
7.1.4 Nanhai Beisha Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.1.5 Nanhai Beisha Pharmaceutical Key News
7.2 Hunan Xiangyikang Pharmaceutical
7.2.1 Hunan Xiangyikang Pharmaceutical Corporate Summary
7.2.2 Hunan Xiangyikang Pharmaceutical Business Overview
7.2.3 Hunan Xiangyikang Pharmaceutical Sulfadiazine API Major Product Offerings
7.2.4 Hunan Xiangyikang Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.2.5 Hunan Xiangyikang Pharmaceutical Key News
7.3 China Resources Double-crane Pharmaceutical
7.3.1 China Resources Double-crane Pharmaceutical Corporate Summary
7.3.2 China Resources Double-crane Pharmaceutical Business Overview
7.3.3 China Resources Double-crane Pharmaceutical Sulfadiazine API Major Product Offerings
7.3.4 China Resources Double-crane Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.3.5 China Resources Double-crane Pharmaceutical Key News
7.4 Yichang Humanwell Pharmaceutical
7.4.1 Yichang Humanwell Pharmaceutical Corporate Summary
7.4.2 Yichang Humanwell Pharmaceutical Business Overview
7.4.3 Yichang Humanwell Pharmaceutical Sulfadiazine API Major Product Offerings
7.4.4 Yichang Humanwell Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.4.5 Yichang Humanwell Pharmaceutical Key News
7.5 Northeast Pharmaceutical Group
7.5.1 Northeast Pharmaceutical Group Corporate Summary
7.5.2 Northeast Pharmaceutical Group Business Overview
7.5.3 Northeast Pharmaceutical Group Sulfadiazine API Major Product Offerings
7.5.4 Northeast Pharmaceutical Group Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.5.5 Northeast Pharmaceutical Group Key News
7.6 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical
7.6.1 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Corporate Summary
7.6.2 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Business Overview
7.6.3 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Sulfadiazine API Major Product Offerings
7.6.4 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.6.5 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Key News
7.7 Southwest Synthetic Pharmaceutical
7.7.1 Southwest Synthetic Pharmaceutical Corporate Summary
7.7.2 Southwest Synthetic Pharmaceutical Business Overview
7.7.3 Southwest Synthetic Pharmaceutical Sulfadiazine API Major Product Offerings
7.7.4 Southwest Synthetic Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.7.5 Southwest Synthetic Pharmaceutical Key News
7.8 Shanghai Zhongxi Sunve Pharmaceutical
7.8.1 Shanghai Zhongxi Sunve Pharmaceutical Corporate Summary
7.8.2 Shanghai Zhongxi Sunve Pharmaceutical Business Overview
7.8.3 Shanghai Zhongxi Sunve Pharmaceutical Sulfadiazine API Major Product Offerings
7.8.4 Shanghai Zhongxi Sunve Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.8.5 Shanghai Zhongxi Sunve Pharmaceutical Key News
7.9 Chongqing Kangle Pharmaceutical
7.9.1 Chongqing Kangle Pharmaceutical Corporate Summary
7.9.2 Chongqing Kangle Pharmaceutical Business Overview
7.9.3 Chongqing Kangle Pharmaceutical Sulfadiazine API Major Product Offerings
7.9.4 Chongqing Kangle Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.9.5 Chongqing Kangle Pharmaceutical Key News
7.10 Adia (Shanghai) Pharma
7.10.1 Adia (Shanghai) Pharma Corporate Summary
7.10.2 Adia (Shanghai) Pharma Business Overview
7.10.3 Adia (Shanghai) Pharma Sulfadiazine API Major Product Offerings
7.10.4 Adia (Shanghai) Pharma Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.10.5 Adia (Shanghai) Pharma Key News
8 Global Sulfadiazine API Production Capacity, Analysis
8.1 Global Sulfadiazine API Production Capacity, 2017-2028
8.2 Sulfadiazine API Production Capacity of Key Manufacturers in Global Market
8.3 Global Sulfadiazine API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sulfadiazine API Supply Chain Analysis
10.1 Sulfadiazine API Industry Value Chain
10.2 Sulfadiazine API Upstream Market
10.3 Sulfadiazine API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sulfadiazine API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|